CRISPR/Cas9-Mediated Gene Knockout to Address Primary Hyperoxaluria

被引：0

作者：

Huebner, Anette ^{[1
]}

Wood, Kyle ^{[2
]}

Dymek, Zachary ^{[1
]}

Odate, Shobu ^{[1
]}

Shaw, Cindy ^{[1
]}

Krumm, Elizabeth ^{[1
]}

Dowell, Alexander ^{[2
]}

Doshi, Vinita ^{[1
]}

Nolasco, Jonathan ^{[1
]}

Wood, Kristy ^{[1
]}

Strapps, Walter ^{[1
]}

Finn, Jonathan D. ^{[1
]}

Holmes, Ross ^{[2
]}

Knight, John ^{[2
]}

Burns, Sean ^{[1
]}

机构：

[1] Intellia Therapeut, Cambridge, MA USA

[2] Univ Alabama Birmingham, Birmingham, AL USA

来源：

MOLECULAR THERAPY | 2019年 / 27卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1000

引用

页码：464 / 465

页数：2

共 50 条

[21] Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout
Jae Hoon Lee
Jong-Hyung Park
Tae-Wook Nam
Sun-Min Seo
Jun-Young Kim
Han-Kyul Lee
Jong Hyun Han
Song Yi Park
Yang-Kyu Choi
Han-Woong Lee
[J]. Transgenic Research, 2018, 27 : 241 - 251
[22] CRISPR/Cas9-Mediated Gene Correction to Understand ALS
Yun, Yeomin
Ha, Yoon
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)
[23] Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing
Ghassemi, Bita
Shamsara, Mehdi
Soleimani, Masoud
Kiani, Jafar
Rassoulzadegan, Minoo
[J]. ANALYTICAL BIOCHEMISTRY, 2019, 568 : 31 - 40
[24] Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout
Lee, Jae Hoon
Park, Jong-Hyung
Nam, Tae-Wook
Seo, Sun-Min
Kim, Jun-Young
Lee, Han-Kyul
Han, Jong Hyun
Park, Song Yi
Choi, Yang-Kyu
Lee, Han-Woong
[J]. TRANSGENIC RESEARCH, 2018, 27 (03) : 241 - 251
[25] CRISPR/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs
Wang, Kankan
Tang, Xiaochun
Xie, Zicong
Zou, Xiaodong
Li, Mengjing
Yuan, Hongming
Guo, Nannan
Ouyang, Hongsheng
Jiao, Huping
Pang, Daxin
[J]. TRANSGENIC RESEARCH, 2017, 26 (06) : 799 - 805
[26] Therapeutic potential of CRISPR/Cas9 mediated in vivo gene editing for primary hyperoxaluria
Zabaleta, N.
Barberia, M.
Zapata-Linares, N.
Rodriguez, S.
Olaguee, C.
Vales, A.
Abizanda, G.
Iglesias, E.
Salido, E.
Prosper, F.
Gonzalez-Aseguinolaza, G.
Rodriguez-Madoz, J. R.
[J]. HUMAN GENE THERAPY, 2016, 27 (11) : A139 - A140
[27] The role of CRISPR/Cas9-mediated Drp1 knockout in ferroptosis
Tang, S.
Fuss, A.
Zika, S.
Culmsee, C.
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S57 - S57
[28] CRISPR/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs
Kankan Wang
Xiaochun Tang
Zicong Xie
Xiaodong Zou
Mengjing Li
Hongming Yuan
Nannan Guo
Hongsheng Ouyang
Huping Jiao
Daxin Pang
[J]. Transgenic Research, 2017, 26 : 799 - 805
[29] CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Xu, Chenchen
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
[30] CRISPR/Cas9-Mediated α-ENaC Knockout in a Murine Pancreatic β-Cell Line
Zhang, Xue
Zhao, Lihua
Jin, Runbing
Li, Min
Li, Mei-Shuang
Li, Rongfeng
Liang, Xiubin
[J]. FRONTIERS IN GENETICS, 2021, 12

← 1 2 3 4 5 →